Largest Trial So Far in Mesothelioma Disappoints – Medscape
Largest Trial So Far in Mesothelioma Disappoints Medscape The phase 3 study was conducted in 660 patients with malignant pleural mesothelioma who had progressed after 1 or 2 systemic therapies, including pemetrexed (Alimta) and cisplatin. All patients received best supportive care, and were randomized to ... |


Thu, Sep 29, 2011
Alimta News